# Curaway

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/curaway

- Industry: Medical Devices & Equipment
- Headquarters: Hangzhou, China
- Website: www.curaway.com
- Latest round: Series C (Apr 21, 2026)
- Investors on record: 7

## About

Based in Hangzhou, China and founded in 2014, Zhejiang Curaway Medical Technology Co., Ltd., dba Curaway, is a medical device company engaged in the research, development and production of minimally invasive surgery devices. The company passed ISO 9000, ISO 9001 international quality certification and owned multiple independent intellectual property rights.

In April 2026, Curaway closed a round of series C funding from Hunan Xingxiang Investment Holding Group, Xin'an Capital, and other investors.

Curaway  offers three main lines of products encompassing minimally invasive surgery devices, surgery consumables and intelligent surgical robots, covering four areas of minimally invasive oncology, peripheral vascular intervention, delicate surgery and intelligent medical technology. The company's surgery devices include energy ablation systems with radio frequency, irreversible electroporation, microwave, etc. models, and monopolar and bipolar delicate devices. As for consumables, Curaway provides disposable biopsy needles, vacuum assisted breast biopsy system and other localization products. As for surgical robots, the company offers surgical robot equipped with CT-guided puncture and interventional surgery navigation system.

The company’s revenue is generated primarily from the sale of its medical devices and equipment to hospitals, clinics, and other healthcare institutions.

The company will use the series C funding in April 2026 for the clinical application and commercialization of new intelligent interventional technologies, accelerating the construction of a minimally invasive interventional platform covering the entire process of "diagnosis-treatment-intelligent positioning".

## Funding rounds

- Series C, Apr 21, 2026 — Hunan Xingxiang Investment Holding Group, Xinan Capital
- Series C, Apr 30, 2024 — Qiantang Industrial Group Capital
- Series B, Feb 14, 2022 — Haier Capital, Hangshi Group
- Series A, Nov 1, 2021 — Haibang Venture, Yantong Investment

## Investors

- Haibang Venture — Series A
- Yantong Investment — Series A
- Haier Capital (https://capitalatlas.ai/funds/haier-capital) — Series B
- Hangshi Group (https://capitalatlas.ai/funds/hangshi-group) — Series B
- Qiantang Industrial Group Capital (https://capitalatlas.ai/funds/qiantang-industrial-group-capital) — Series C
- Hunan Xingxiang Investment Holding Group (https://capitalatlas.ai/funds/hunan-xingxiang-investment-holding-group) — Series C
- Xinan Capital (https://capitalatlas.ai/funds/xinan-capital) — Series C